InMode Reports First Quarter 2026 Financial Performance with Revenue Growth Amid Challenges

InMode's Financial Report for Q1 2026

InMode Ltd. (Nasdaq: INMD), a prominent global name in innovative medical technology, has unveiled its financial results for the first quarter of 2026. The company reported a GAAP revenue of $82 million, marking a 5% increase from $77.9 million in the same quarter last year. This positive growth reflects InMode's resilience in a challenging macroeconomic landscape.

Key Highlights

During the first quarter, InMode generated revenues from consumables and services amounting to $21.4 million, a 6% rise compared to the previous year. The gross margin stood at 75%, slightly below the 78% achieved in Q1 2025. The operating income for the quarter was recorded at $10.1 million, with a non-GAAP operating income of $14 million. These figures illustrate InMode's capacity to maintain profitability despite rising costs and structural changes in its sales operations.

As of March 31, 2026, InMode held a robust cash position of $537.2 million, which includes cash and cash equivalents, marketable securities, and short-term bank deposits. Additionally, the company made significant shareholder returns, repurchasing 2.55 million ordinary shares and returning $34.8 million back to its investors.

Management Insights

CEO Moshe Mizrahy expressed optimism despite the ongoing macroeconomic uncertainties, stating, "Our total revenue this quarter reached our expectations; however, our profitability was lower than anticipated." Mizrahy emphasized the importance of re-shaping InMode's sales and management teams in North America and Europe to enhance performance and adapt to market demands.

CFO Yair Malca commented, "We are encouraged by the Q1 revenue increase of 5%, with significant contributions from the U.S. market, showcasing our consistent capability to execute in a softer market environment." Malca affirmed the company's focus on generating cash and maintaining its operational efficiency.

Changes in Leadership

The report also noted changes in the company's leadership structure. Dr. Michael Anghel resigned from the Board of Directors and was replaced by Dr. Hadar Ron as the Interim Chair. Yair Malca stepped down as CFO but will assist in the transition as a consultant for six months. These changes are part of InMode’s strategy to adapt to evolving market conditions and enhance its operational framework.

Future Outlook

InMode has provided a forecast for the fiscal year ending December 31, 2026, anticipating revenues between $365 million and $375 million. It expects non-GAAP gross margins to range from 74% to 76%. Management’s outlook, while optimistic, highlighted the unpredictability of external factors that could influence future performance.

Current Situation Overview

Regarding the recent geopolitical climate in Israel, where InMode is located, the situation remains unstable post a ceasefire agreement. Nonetheless, InMode continues to monitor developments closely without any significant operational impacts reported so far.

In summary, InMode's Q1 2026 financial results exhibit a commendable revenue increase amidst a transitional phase within the company and the broader economic landscape. With a firm cash position and ongoing strategic adjustments, InMode appears poised to capitalize on future growth opportunities in the medical technology sector.